Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung CancerHirofumi Mikami, Tomoyuki Igawa|Cancer Immunology Research|2024Cited by 22
SAIL66, a next generation CLDN6-targeting T-cell engager, demonstrates potent antitumor efficacy through dual binding to CD3/CD137Takayuki Kamikawa, Tomoyuki Igawa|Journal for ImmunoTherapy of Cancer|2024Cited by 13